Biopharma digital maturity benchmark assessment has been saved
Analysis
Biopharma digital maturity benchmark assessment
How does your company’s tech innovation stack up against the competition?
As the pace of tech innovation in biopharma accelerates exponentially, digital maturity rises to the top of the strategic priority list. But with so much transformation in motion, it can be hard to identify and understand gaps in digital maturity and how your company compares to its peers. Find out how your organization’s digital innovation progress stacks up to an industry benchmark by taking our assessment. And use your results to help engineer—and maintain—a competitive advantage.
Increase your digital innovation IQ: Elevate your digital maturity
Biopharma organizations face a critical choice: decelerate the current pace of innovation or raise the bar even higher by accelerating the adoption of digital technologies. Based on our research and experience with clients, many leaders are now willing to invest, take risks, and digitally innovate to stay ahead of the competition. Is your company ready to do the same?
By taking our biopharma digital maturity benchmark assessment, you can help your company discover if it’s leading the innovation charge or has catching up to do. The assessment is divided into four modules that each can be completed in under five minutes. You will be able to select which modules you want to complete, and once you’re finished, you will:
Take the biopharma digital maturity assessment
Are you ready to see how your company’s digital maturity stacks up against its peers? To get started, select one—or all—of the sections below.
Why take the assessment
Take the assessment to:
Receive a digital innovation maturity ranking, and find out if you’re at the Foundational, Emerging, or on the Cutting-edge maturity level for the selected modules.
Understand how your organization’s digital innovation maturity matches up against its peers and areas where further analysis could help
Obtain tactical recommendations to help advance your organization’s digital innovation maturity
Learn about the technologies and use cases powering the next wave of digital capabilities across each function of the biopharma value chain
With your results, you’ll be able to help your organization begin to:
- Establish digital innovation north stars that provide ambitious targets leveraging the power of digital technologies
- Develop a purposeful portfolio of digital innovations that cohesively build on one another to realize north star aspirations
- Build a business case for needed digital innovation investments
An assessment grounded in biopharmaceutical digital maturity data
In 2021, we surveyed 150 executives from some of the largest biopharma companies (revenue of US$1 billion and above) across the United States, Europe, and Asia. Survey respondents included vice presidents, directors, and C-level executives from functions across the biopharma value chain.
The primary objective was to understand how biopharma companies were developing a competitive edge using digital innovation. The assessment consisted of more than 40 questions that were centered on four categories:
Learn more about the data gathered from the assessment and explore four critical considerations for companies to accelerate their digital innovation journey in the report.
Biopharma digital transformation: Gain an edge with leapfrog digital innovation
Determine your path forward
The momentum and importance of digital innovation in biopharma isn’t slowing down—it’s accelerating to become a new competitive advantage for organizations. We hope the assessment helped you better understand your organization’s digital innovation maturity so it can navigate and strategize for the journey ahead.
The biopharma benchmark assessment represents a sampling of the key topics and questions that Deloitte can help to address to improve digital innovation maturity. Our suite of offerings can help your organization achieve the digital edge that it needs to thrive in the future of health.
Get in touch
Todd Konersmann
Deloitte Global Life Sciences Sector leader | Principal | Deloitte Consulting LLP | Deloitte United States
